- Presents the physiological and psychological bases in the development of pain and its persistence
- Captures advances in scientific data and pharmacological and nonpharmacological treatments
- Provides the necessary understanding to adapt treatment depending on the type of pain
Introducing the latest edition of
The Phenomenon of Pain: A Comprehensive Exploration of Pain Mechanisms and Therapeutic Approaches.
In recent decades, pain has emerged as a focal point in both basic and clinical research, reflecting its profound impact on individuals' lives. The rapid advancement of knowledge has deepened our understanding of the complex neurophysiological and psychological mechanisms underlying pain, shedding light on its multifaceted nature.
Clinicians grapple daily with the daunting reality of human suffering, navigating its intricate web of causes and manifestations. This continuous engagement with pain presents significant and stressful challenges from the relentless pursuit of understanding and alleviating it.
This book transcends mere discourse on the physiological and psychological underpinnings of pain; it delves into the intricate factors contributing to its persistence. Furthermore, it meticulously examines pharmacological and nonpharmacological treatment modalities, forging a crucial link between the mechanisms of pain and therapeutic interventions.
By bridging the gap between pain mechanisms and treatment strategies, this edition equips clinicians with invaluable insights to augment their clinical acumen. Armed with this knowledge, clinicians can tailor interventions to effectively address the diverse array of pain presentations encountered in their practice.
Table of ContentsChapter 1. History of Cardiovascular Epidemiology.- Chapter 2. Types of Cardiovascular Outcomes Studies.- Chapter 3. Basic Statistical Considerations for Cardiovascular Outcomes Studies.- Chapter 4. Evolving Concepts in Cardiovascular Outcomes Studies.- Chapter 5. Current Guidelines for Atherosclerotic Cardiovascular Disease Risk Reduction.- Chapter 6. Surrogate Markers of Cardiovascular Disease.- Chapter 7. Challenges in Developing Evidence-based Recommendations for Non-pharmacological Interventions for Atherosclerotic Cardiovascular Disease Risk Reduction.- Chapter 8. Overview of the Pharmaceutical Development Process for Agents to Influence Cardiovascular Health.- Chapter 9. Lipids and Cardiovascular Outcomes.- Chapter 10. Inflammation and Cardiovascular Outcomes.- Chapter 11. Hemostasis and Cardiovascular Outcomes.- Chapter 12. Cardiac Rhythms and Cardiovascular Outcomes.- Chapter 13. Blood Pressure and CardiovascularOutcomes.- Chapter 14. Diabetes, Obesity, Metabolic Syndrome and Cardiovascular Outcomes.- Chapter 15. Chronic Kidney Disease and Cardiovascular Outcomes.
